Reliance Jio Platforms tops 400M subscribers, explores expanding services outside of India
Smartphone shipments dip in China for Q3, led by Huawei decline
Studies link COVID-19 deaths to air pollution, raising questions about EPA's 'acceptable risk'
Futures Rebound From Overnight Tech Wreck
Investors eye China PMIs
Livin’ in a FAANGsTa’s paradise
US recovery not evident in Asia
Starbucks Tops 4Q Estimates, Sees Strong Global Comps In FY21
Plenty of Reasons to Buy into the Alibaba Story, Says Oppenheimer
New Research Points To The People's Liberation Army Hospital In Wuhan As Origin For Global Coronavirus Pandemic
AAPL Plunges After iPhone Sales Miss, China Revenues Plummet, Lack Of Forecast
All Eyes on FAANG Stocks Ahead of Earnings; JPMorgan Cheers
Global COVID-19 Cases Near 45 Million After Another Record Day: Live Updates
Crude Prices Are Collapsing To 5-Month Lows After Lagarde Comments
Does coronavirus spread more easily in cold temperatures? Here's what we know
Remdesivir for COVID-19: FDA approved but still unproven
Stocks Struggle To Stabilize After Worst Rout Since June
Covid-19 roundup: Boehringer pulls a drug out of the pipeline for a PhII Covid-19 trial; Novavax delays PhIII trial in US, with PhII data coming Friday
Sell, Mortimer! Sell!
Equity markets are resilient in Asia
On Twitter, bots spread conspiracy theories and QAnon talking points
Hang Seng introduces Chinese e-commerce index
Why young people tune out government COVID-19 messaging
Election 2020 chatter on Twitter busy with bots, conspiracy theorists, USC study finds
Sanofi, GSK to supply vaccine doses to WHO-backed alliance
NTU spin-off ARTICARES launches portable arm rehabilitation device
More testing means more iceberg
Covid-19 roundup: Boehringer pulls a drug out of the pipeline for a PhII Covid-19 trial; Novavax delays PhIII trial in US, with PhII data coming Friday;
News briefing: SpringWorks, Jazz exchange $35M and PTSD drug; Dr. Reddy's says cyberattack was ransomware
US Oil's Merger Mania Won't End Well For Energy